Search Results - "Firstova, V. V."

Refine Results
  1. 1

    Next-Generation Antibiotics, Bacteriophage Endolysins, and Nanomaterials for Combating Pathogens by Shemyakin, I. G., Firstova, V. V., Fursova, N. K., Abaev, I. V., Filippovich, S. Yu, Ignatov, S. G., Dyatlov, I. A.

    Published in Biochemistry (Moscow) (01-11-2020)
    “…This review presents various strategies to fight causative agents of infectious diseases. Species-specific programmable RNA-containing antibiotics open up new…”
    Get full text
    Journal Article
  2. 2

    Identification of Immunological Correlates of Protection during Development of Specific Immunity to Francisella tularensis by Kartseva, A. S., Silkina, M. V., Ivashchenko, T. A., Romanenko, Ya. O., Sayapina, L. V., Firstova, V. V.

    Published in Problemy osobo opasnyh infekcij (01-10-2024)
    “…Live tularemia vaccine is one of the most effective bacterial vaccines. However, it also has high residual virulence for laboratory animals and may cause…”
    Get full text
    Journal Article
  3. 3

    Humoral immune response to shiga toxin 2 (Stx2) in children with escherichiosis with hemolytic-uremic syndrome by Shkuratova, Maria A., Khlyntseva, A. E., Kalmantaeva, O. V., Kartsev, N. N., Muzurov, A. L., Firstova, V. V.

    Published in Infekt͡s︡ii͡a︡ i immunitet (28-07-2024)
    “…Shiga toxin-producing Escherichia coli (STEC) causes acute intestinal infections and also causes acute renal failure, especially in children. Shiga toxins…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Evaluation of the long-term memory T cell in mice after immunization with a live tularemia vaccine by Kartseva, A. S., Silkina, M. V., Titareva, G. M., Kombarova, T. I., Mironova, R. I., Firstova, V. V.

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (01-06-2023)
    “…The vaccine strain F. tularensis 15 NIIEG induces long-lived cell-mediated immunity but exhibits a certain reactogenicity and genetic instability. Progress in…”
    Get full text
    Journal Article
  6. 6

    Antibiotic Adjuvant 4-Hexylresorcinol Enhances the Efficiency of Antituberculosis Drugs by Nikolaev, Yu. A., Mukhina, T. N., Potapov, V. D., Kuznetsov, B. B., El’-Registan, G. I., Firstova, V. V., Shemyakin, I. G., Manzenyuk, O. Yu

    “…We studied the possibility of using 4-hexylresorcinol to increase the efficiency of anti-mycobacterial chemotherapy. In an in vitro experiment,…”
    Get full text
    Journal Article
  7. 7

    Stress-Tolerant Dormant Bacterial Forms: Biological and Ultrastructural Properties of Moraxella catarrhalis and Kocuria rhizophila by Manzenyuk, O. Yu, Suzina, N. E., Nikolaev, Yu. A., Mukhina, T. N., Firstova, V. V., El’-Registan, G. I., Shemyakin, I. G., Dyatlov, I. A.

    “…Dormant forms of causative agents of healthcare-acquired infections Moraxella catarrhalis and Kocuria rhizophila have been obtained. Dormant forms cells…”
    Get full text
    Journal Article
  8. 8

    Current understanding of Bacillus anthracis toxin molecules organization and approaches for blocking their cytotoxic action by Firstova, V. V., Shemyakin, I. G., Dyatlov, I. A.

    Published in Infekt͡s︡ii͡a︡ i immunitet (01-02-2020)
    “…Here, we review the data on mechanisms inhibiting cytotoxic effect of anthrax toxin on the immune system cells. Various disease forms, immunopathogenesis and…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Selection of Candidate Monoclonal Antibodies for Therapy of Botulinum Toxin Type A Intoxications by Zeninskaya, Natalia A, Ryabko, Alena K, Marin, Maksim A, Kombarova, Tatyana I, Shkuratova, Maria A, Rogozin, Methun M, Silkina, Marina V, Romanenko, Yana O, Ivashchenko, Tatiana A, Shemyakin, Igor G, Firstova, Victoria V

    Published in Toxins (01-07-2024)
    “…Botulism is one of the most serious food intoxications, manifesting as prolonged paralytic conditions. This disease is usually the result of the consumption of…”
    Get full text
    Journal Article
  11. 11

    Optimization of Electrofusion Parameters for Producing Hybridomas Synthesizing Human Monoclonal Antibodies by Silkina, M. V., Kartseva, A. S., Ryabko, A. K., Marin, M. A., Romanenko, Ya. O., Kalmantaeva, O. V., Khlyntseva, A. E., Shemyakin, I. G., Dyatlov, I. A., Firstova, V. V.

    Published in Applied biochemistry and microbiology (01-12-2022)
    “…Monoclonal antibodies are an established treatment for many illnesses, including cancer, toxicity and infectious diseases. The goal of this work was to…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Characterization of the C6D7-RBD Human Monoclonal Antibody Specific to the SARS-CoV-2 S Protein Receptor-Binding Domain by Romanenko, Ya O, Silkina, M V, Kartseva, A S, Marin, M A, Shkuratova, M A, Makarova, M A, Ryabko, A K, Konyshkova, D A, Zeninskaya, N A, Khlyntseva, A E, Shemyakin, I G, Firstova, V V

    Published in Actanaturae (01-01-2023)
    “…The new coronavirus infection COVID-19 is an acute viral disease that affects primarily the upper respiratory tract. The etiological agent of COVID-19 is the…”
    Get full text
    Journal Article
  15. 15

    Characterization of Immunogenic and Protective Properties of the Modified Variants of the Strain Francisella tularensis 15 NIIEG by Kartseva, A. S., Kalmantaeva, O. V., Silkina, M. V., Kombarova, T. I., Pavlov, V. M., Mokrievich, A. N., Firstova, V. V.

    Published in Problemy osobo opasnyh infekcij (22-10-2020)
    “…Francisella tularensis is an intracellular bacterium that causes tularemia. Progress in creating a safe and effective vaccine for the prevention of tularemia…”
    Get full text
    Journal Article
  16. 16

    Antibacterial and Immunomodulating Activity of Silver Nanoparticles on Mice Experimental Tuberculosis Model by Kalmantaeva, O. V., Firstova, V. V., Grishchenko, N. S., Rudnitskaya, T. I., Potapov, V. D., Ignatov, S. G.

    Published in Applied biochemistry and microbiology (01-03-2020)
    “…The antibacterial activity of silver nanoparticles with a size of 43.6 ± 10.7 nm against strain Mycobacterium tuberculosis H37Rv was studied in vitro (the…”
    Get full text
    Journal Article
  17. 17

    Mechanism of Action of Monoclonal Antibodies That Block the Activity of the Lethal Toxin of Bacillus Anthracis by Romanenko, Ya O, Riabko, A K, Marin, M A, Kartseva, A S, Silkina, M V, Shemyakin, I G, Firstova, V V

    Published in Actanaturae (01-10-2021)
    “…Neutralization of the lethal toxin of Bacillus anthracis is an important topic of both fundamental medicine and practical health care, regarding the fight…”
    Get full text
    Journal Article
  18. 18

    Molecular Lipopolysaccharide Di-Vaccine Protects from Shiga-Toxin Producing Epidemic Strains of Escherichia coli O157:H7 and O104:H4 by Dyatlov, Ivan A., Svetoch, Edward A., Mironenko, Anna A., Eruslanov, Boris V., Firstova, Victoria V., Fursova, Nadezhda K., Kovalchuk, Alexander L., Lvov, Vyacheslav L., Aparin, Petr G.

    Published in Vaccines (Basel) (01-11-2022)
    “…Background: Shiga toxin-producing Escherichia coli (STEC) O157:H7 and O104:H4 strains are important causative agents of food-borne diseases such as hemorrhagic…”
    Get full text
    Journal Article
  19. 19

    Detecting specific memory t and b cells in volunteers annually revaccinated with live anthrax vaccine by Firstova, V. V., Kartseva, A. S., Silkina, M. V., Marin, M. A., Muntian, Ia. O., Ryabko, A. K., Shemyakin, I. G.

    Published in Infekt͡s︡ii͡a︡ i immunitet (14-11-2019)
    “…Currently, live anthrax vaccine has been used for vaccine prophylaxis in Russia and neighbor countries for seve ral decades, but precise mechanism of…”
    Get full text
    Journal Article
  20. 20